Stock APLS APELLIS PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Chart Apellis Pharmaceuticals, Inc.

Equities

APLS

US03753U1060

Real-time Estimate Cboe BZX
Other stock markets
 02:32:31 2024-05-30 pm EDT 		5-day change 1st Jan Change
40.86 USD -0.61% Intraday chart for Apellis Pharmaceuticals, Inc. +2.09% -32.33%
May. 24 Apellis Pharmaceuticals, Sobi Say Pegcetacoplan Reduces Post-Transplant Kidney Diseases MT
May. 24 Apellis Pharmaceuticals, Inc. Announces Positive One-Year Data from Phase 2 Study of Pegcetacoplan in Post-Transplant Recurrence of C3G and IC-MPGN Presented as Late-Breaker at ERA Congress CI
7b5a.I9CHIVK55983wh1fYhC9I2litaxB-wZjySkkgfOvl2E.ZIXpYDfdlqpfjUkmU1zvEj0XxpwjzXBWoU5B-KnV4llAiMgVZ9uFqnCDfg~0b9da5942584d4c316fabc0c724044b3
  1. Stock Market
  2. Equities
  3. APLS Stock
  4. Charts Apellis Pharmaceuticals, Inc.
  5. News Chart